Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2020	$ 1,964	$ 102,651,304	$ (98,234,151)	$ 160,642	$ 4,579,759
Balances (in Shares) at Dec. 31, 2020	19,642,401
Stock-based compensation		626,579			626,579
Convertible note converted to common stock	$ 3	124,077			124,080
Convertible note converted to common stock (in Shares)	32,950
Cashless stock option exercise	$ 18	(18)
Cashless stock option exercise (in Shares)	178,120
Cashless warrant exercise	$ 26	(26)
Cashless warrant exercise (in Shares)	262,759
Net loss			(2,489,999)		(2,489,999)
Foreign currency translation				40,356	40,356
Balances at Mar. 31, 2021	$ 2,011	103,401,916	(100,724,150)	200,998	2,880,775
Balances (in Shares) at Mar. 31, 2021	20,116,230
Balances at Dec. 31, 2021	$ 2,329	126,581,702	(115,899,939)	211,486	10,895,578
Balances (in Shares) at Dec. 31, 2021	23,294,024
Stock-based compensation		1,866,989			1,866,989
Sale of common stock for cash, net of offering costs	$ 106	3,146,834			3,146,940
Sale of common stock for cash, net of offering costs (in Shares)	1,063,514
Common stock issued with convertible debt	$ 3	91,754			91,757
Common stock issued with convertible debt (in Shares)	28,496
Common stock issued for working capital facility	$ 10	302,990			303,000
Common stock issued for working capital facility (in Shares)	100,000
Warrants for services with the issuance of convertible debt		449,474			449,474
Cashless stock option exercise	$ 19	(19)
Cashless stock option exercise (in Shares)	185,111
Cashless warrant exercise (in Shares)	1,377
Net loss			(5,300,728)		(5,300,728)
Foreign currency translation				32,740	32,740
Balances at Mar. 31, 2022	$ 2,467	$ 132,439,724	$ (121,200,667)	$ 244,226	$ 11,485,750
Balances (in Shares) at Mar. 31, 2022	24,672,522